September 25, 2018
Rose
Shingrix, the vaccine approved last year to prevent shingles, has proved so popular that its maker, GlaxoSmithKline, has not been able to produce it quickly enough.
from Health https://ift.tt/2xBc2Ys
September 25, 2018
Rose
Health, Health - The New York Times
No comments
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment